CFD 属于复杂的高风险金融工具，其杠杆作用可能导致投资者迅速亏损。 84% 的散户投资者因进行 CFD 交易遭受资金损失。 请您谨慎考虑自己是否了解 CFD 操作，以及是否能够接受高额亏损的风险。
US 简体中文
國家 • United States
    實體 • The products and services listed on this website are not available to US residents.
    English العَرَبِيَّة Bahasa Indonesia Български Čeština Dansk Deutsch Eesti ελληνικά Español Français Hrvatski Italiano Latviešu Lietuvių Magyar Nederlands Polski Português Română Русский Slovenčina Slovenščina Suomi Svenska Tiếng Việt ไทย 简体中文 繁體中文

    交易 Black Diamond Therapeutics, Inc. - BDTX CFD

    2.4564
    5.58%
    • 概括
    • 历史数据
    • 活动
    • 收入报表
    • 资产负债表
    • 现金流
    • 所有权
    交易条件
    价差 0.0672
    多头隔夜费

    Long position overnight fee

    Margin. Your investment $1,000.00
    隔夜费用 -0.025457 %
    Charges from borrowed part ($-1.02)
    Trade size with leverage ~ $5,000.00
    Money from leverage ~ $4,000.00
    前往平台
    		-0.025457%
    空头隔夜费

    Short position overnight fee

    Margin. Your investment $1,000.00
    隔夜费用 0.003235 %
    Charges from borrowed part ($0.13)
    Trade size with leverage ~ $5,000.00
    Money from leverage ~ $4,000.00
    前往平台
    		0.003235%
    隔夜费时间 21:00 (UTC)
    最小交易量 1
    货币 USD
    保证金 20%
    上市交易所 United States of America
    交易费 0%

    *Information provided by Capital.com

    Black Diamond Therapeutics Inc ESG Risk Ratings

    High Medium Low Negligible

    ‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.

    关键数据
    前收盘价* 2.3266
    开仓* 2.3465
    1 年变化* 33.32%
    日范围* 2.3465 - 2.4963
    52 周范围 1.18-4.08
    平均交易量（10 天） 74.14K
    平均交易量（3 个月) 1.74M
    市值 85.44M
    市盈率 -100.00K
    流通股 36.51M
    收入 N/A
    EPS -2.38
    股息（收益率 %） N/A
    贝塔 1.89
    下一个财报发布日期 Aug 7, 2023

    所有数据都是由Refinitiv提供的， 除了标有星号的数据， 这是*由 Capital.com 提供的数据

    • Last Week
    • Last Month
    • Last Year
    • Last two Years
    • Max
    • Daily
    • Weekly
    • Monthly
    Date 平仓 Change Change (%) 開倉 High Low
    Jun 5, 2023 2.4564 0.1998 8.85% 2.2566 2.5063 2.2366
    Jun 2, 2023 2.3266 0.1399 6.40% 2.1867 2.3665 2.0969
    Jun 1, 2023 2.1368 0.3295 18.23% 1.8073 2.1668 1.7973
    May 31, 2023 1.8373 0.0300 1.66% 1.8073 1.8572 1.7973
    May 30, 2023 1.8572 0.0999 5.68% 1.7573 1.8772 1.7573
    May 26, 2023 1.7673 0.0699 4.12% 1.6974 1.7774 1.6575
    May 25, 2023 1.7274 0.0699 4.22% 1.6575 1.7574 1.6575
    May 24, 2023 1.6974 0.0100 0.59% 1.6874 1.7374 1.6375
    May 23, 2023 1.6775 -0.1298 -7.18% 1.8073 1.8672 1.6774
    May 22, 2023 1.8373 0.0899 5.14% 1.7474 1.8772 1.7474
    May 19, 2023 1.7773 0.0699 4.09% 1.7074 1.7873 1.6175
    May 18, 2023 1.5976 -0.0998 -5.88% 1.6974 1.6975 1.5576
    May 17, 2023 1.7074 -0.0400 -2.29% 1.7474 1.7674 1.6774
    May 16, 2023 1.7673 -0.1198 -6.35% 1.8871 1.9171 1.7673
    May 15, 2023 1.9171 0.1198 6.67% 1.7973 1.9271 1.7573
    May 12, 2023 1.8672 -0.0399 -2.09% 1.9071 1.9071 1.8073
    May 11, 2023 1.9171 0.1098 6.08% 1.8073 1.9970 1.7973
    May 10, 2023 1.8472 0.0499 2.78% 1.7973 1.8972 1.7973
    May 9, 2023 1.8173 0.0400 2.25% 1.7773 1.8173 1.6575
    May 8, 2023 1.9072 0.0300 1.60% 1.8772 1.9371 1.8572

    Black Diamond Therapeutics, Inc. Events

    时间（协调世界时） (UTC) 国家/地区 事件
    Friday, June 9, 2023

    时间（协调世界时） (UTC)

    16:45

    国家/地区

    US

    事件

    Black Diamond Therapeutics Inc at Jefferies Healthcare Conference
    Black Diamond Therapeutics Inc at Jefferies Healthcare Conference

    Forecast

    -

    Previous

    -
    Monday, August 7, 2023

    时间（协调世界时） (UTC)

    12:30

    国家/地区

    US

    事件

    Q2 2023 Black Diamond Therapeutics Inc Earnings Release
    Q2 2023 Black Diamond Therapeutics Inc Earnings Release

    Forecast

    -

    Previous

    -
    Monday, November 6, 2023

    时间（协调世界时） (UTC)

    13:30

    国家/地区

    US

    事件

    Q3 2023 Black Diamond Therapeutics Inc Earnings Release
    Q3 2023 Black Diamond Therapeutics Inc Earnings Release

    Forecast

    -

    Previous

    -
    查看所有活動
    • 年度
    • 每季度
    2022 2021 2020 2019 2018
    总收入 0 0 0 0 0
    总营业费用 92.828 126.872 69.57 29.332 8.904
    销售/一般/行政费用，总计 28.391 30.043 21.361 7.579 1.954
    研究与开发 64.437 96.829 48.209 21.753 6.95
    异常费用（收入） 0
    营业收入 -92.828 -126.872 -69.57 -29.332 -8.904
    利息收入（费用），非经营净值 -0.219 3.464 4.041 -5.932 -0.011
    其他，净值 -0.354 -2.188 -1.725 0.006 -0.016
    税前净收入 -91.169 -125.596 -67.254 -35.258 -8.931
    税后净收入 -91.169 -125.596 -67.254 -35.258 -8.931
    未计算非常项目前的净收益 -91.169 -125.596 -67.254 -35.258 -8.931
    净收入 -91.169 -125.596 -67.254 -35.258 -8.931
    普通股股东可获收益 (不含非经常性项目) -91.169 -125.596 -67.254 -35.258 -8.931
    普通股股东可获收益 (含非經常性項目) -91.169 -125.596 -67.254 -35.258 -8.931
    摊薄净收入 -91.169 -125.596 -67.254 -35.258 -8.931
    摊薄后加权平均股 36.3256 36.189 32.9071 32.6364 32.6364
    扣除特别项目的每股摊薄盈利 -2.50977 -3.47056 -2.04375 -1.08033 -0.27365
    Dividends per Share - Common Stock Primary Issue 0
    每股正常摊薄盈利 -2.57122 -3.47056 -2.04375 -1.08033 -0.27365
    Gain (Loss) on Sale of Assets 2.232
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    总收入 0 0 0 0 0
    总营业费用 21.561 21.852 22.124 23.173 25.679
    销售/一般/行政费用，总计 6.808 7.243 6.277 6.978 7.893
    研究与开发 14.753 14.609 15.847 16.195 17.786
    营业收入 -21.561 -21.852 -22.124 -23.173 -25.679
    利息收入（费用），非经营净值 0.622 -1.573 0.562 0.386 0.406
    其他，净值 0.064 0.115 -0.092 -0.143 -0.234
    税前净收入 -20.875 -21.078 -21.654 -22.93 -25.507
    税后净收入 -20.875 -21.078 -21.654 -22.93 -25.507
    未计算非常项目前的净收益 -20.875 -21.078 -21.654 -22.93 -25.507
    净收入 -20.875 -21.078 -21.654 -22.93 -25.507
    普通股股东可获收益 (不含非经常性项目) -20.875 -21.078 -21.654 -22.93 -25.507
    普通股股东可获收益 (含非經常性項目) -20.875 -21.078 -21.654 -22.93 -25.507
    摊薄净收入 -20.875 -21.078 -21.654 -22.93 -25.507
    摊薄后加权平均股 36.4839 36.3902 36.3462 36.2939 36.2713
    扣除特别项目的每股摊薄盈利 -0.57217 -0.57922 -0.59577 -0.63179 -0.70323
    Dividends per Share - Common Stock Primary Issue 0 0 0 0
    每股正常摊薄盈利 -0.57217 -0.64056 -0.59577 -0.63179 -0.70323
    Gain (Loss) on Sale of Assets 2.232
    • 年度
    • 每季度
    2022 2021 2020 2019 2018
    流动资产总额 127.706 215.703 319.554 155.714 51.684
    现金和短期投资 122.807 209.786 315.067 154.666 51.66
    现金等价物 34.315 65.799 34.605 154.666 51.66
    Prepaid Expenses 4.899 5.917 4.487 1.048 0.024
    Total Assets 156.255 247.682 329.67 158.295 51.826
    Property/Plant/Equipment, Total - Net 27.381 30.74 8.787 0.164 0.134
    Property/Plant/Equipment, Total - Gross 28.131 31.109 8.951 0.276 0.234
    Accumulated Depreciation, Total -0.75 -0.369 -0.164 -0.112 -0.1
    Other Long Term Assets, Total 1.168 1.239 1.329 2.417 0.008
    Total Current Liabilities 15.261 23.642 14.218 4.863 2.575
    Accounts Payable 1.877 4.107 2.538 1.964 0.416
    Accrued Expenses 13.384 19.535 11.68 2.899 0.452
    Notes Payable/Short Term Debt 0 0 0 0 0
    Other Current Liabilities, Total 0 1.707
    Total Liabilities 40.56 51.782 21.912 4.879 6.598
    Total Long Term Debt 0 0 0 0 0
    Other Liabilities, Total 25.299 28.14 7.694 0.016 4.023
    Total Equity 115.695 195.9 307.758 153.416 45.228
    Preferred Stock - Non Redeemable, Net 0 0 60.77
    Common Stock 0.005 0.005 0.005 0.001 0.001
    Additional Paid-In Capital 452.503 440.129 425.363 3.812 0.169
    Retained Earnings (Accumulated Deficit) -334.989 -243.82 -118.224 -50.97 -15.712
    Total Liabilities & Shareholders’ Equity 156.255 247.682 329.67 158.295 51.826
    Total Common Shares Outstanding 36.4343 36.2346 36.0784 32.6364 32.6364
    Redeemable Preferred Stock 0 0 200.573
    短期投资 88.492 143.987 280.462
    Other Equity, Total -0.414 0.614
    Unrealized Gain (Loss) -1.824
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    流动资产总额 107.977 127.706 150.978 168.558 188.304
    现金和短期投资 103.366 122.807 144.181 160.89 179.739
    现金等价物 39.141 34.315 53.96 55.877 54.081
    短期投资 64.225 88.492 90.221 105.013 125.658
    Prepaid Expenses 4.611 4.899 6.797 7.668 8.565
    Total Assets 135.582 156.255 180.416 198.834 219.482
    Property/Plant/Equipment, Total - Net 26.437 27.381 28.27 29.098 29.945
    Property/Plant/Equipment, Total - Gross 27.282 28.131 28.98 29.681 30.439
    Accumulated Depreciation, Total -0.845 -0.75 -0.71 -0.583 -0.494
    Other Long Term Assets, Total 1.168 1.168 1.168 1.178 1.233
    Total Current Liabilities 12.847 15.261 21.143 19.706 19.469
    Accounts Payable 3.046 1.877 5.76 2.222 1.883
    Accrued Expenses 9.801 13.384 15.383 17.484 17.586
    Notes Payable/Short Term Debt 0 0 0 0 0
    Total Liabilities 37.392 40.56 47.185 46.463 46.922
    Total Long Term Debt 0 0 0 0 0
    Other Liabilities, Total 24.545 25.299 26.042 26.757 27.453
    Total Equity 98.19 115.695 133.231 152.371 172.56
    Preferred Stock - Non Redeemable, Net 0 0 0 0
    Common Stock 0.005 0.005 0.005 0.005 0.005
    Additional Paid-In Capital 455.225 452.503 449.625 446.909 443.657
    Retained Earnings (Accumulated Deficit) -355.864 -334.989 -313.911 -292.257 -269.327
    Other Equity, Total -1.176 -1.824 -2.488 -2.286 -1.775
    Total Liabilities & Shareholders’ Equity 135.582 156.255 180.416 198.834 219.482
    Total Common Shares Outstanding 36.512 36.4343 36.3662 36.3157 36.2876
    Redeemable Preferred Stock
    • 年度
    • 每季度
    2022 2021 2020 2019 2018
    净收入/起跑线 -91.169 -125.596 -67.254 -35.258 -8.931
    经营活动产生的现金 -85.082 -100.148 -52.146 -24.674 -8.454
    经营活动产生的现金 0.508 0.205 0.052 0.047 0.044
    非现金物品 15.48 18.223 10.014 10.074 0.079
    营运资金的变化 -9.901 7.02 5.042 0.463 0.354
    投资活动产生的现金 53.366 130.613 -281.691 -0.021 -0.076
    资本支出 -0.192 -2.71 -0.142 -0.021 -0.076
    其他投资现金流量项目，总计 53.558 133.323 -281.549 0
    融资活动产生的现金 0.177 0.729 214.944 127.756 52.312
    融资现金流项目 0 -1.743 0
    股票的发行（报废），净额 0.177 0.729 214.944 129.499 52.312
    债务的发行（退还），净额 0
    现金净变化 -31.539 31.194 -118.893 103.061 43.782
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Net income/Starting Line -20.875 -91.169 -70.091 -48.437 -25.507
    Cash From Operating Activities -20.031 -85.082 -63.143 -46.667 -28.6
    Cash From Operating Activities 0.122 0.508 0.382 0.253 0.125
    Non-Cash Items 3.507 15.48 11.804 8.366 4.293
    Changes in Working Capital -2.785 -9.901 -5.238 -6.849 -7.511
    Cash From Investing Activities 24.806 53.366 51.044 36.537 16.729
    Capital Expenditures 0 -0.192 -0.192 -0.2 -0.007
    Other Investing Cash Flow Items, Total 24.806 53.558 51.236 36.737 16.736
    Cash From Financing Activities 0.051 0.177 0.205 0.153 0.153
    Issuance (Retirement) of Stock, Net 0.051 0.177 0.205 0.153 0.153
    Net Change in Cash 4.826 -31.539 -11.894 -9.977 -11.718
    投资者名称 投资者类型 流通股百分比 持有股份 股份变动 持有日期 换手率
    Versant Ventures Venture Capital 17.6634 6449348 0 2023-03-15 LOW
    Bellevue Asset Management AG Investment Advisor 14.778 5395839 -5000 2023-03-31 LOW
    New Enterprise Associates (NEA) Venture Capital 9.4454 3448757 0 2023-03-31 LOW
    RA Capital Management, LP Hedge Fund 7.0932 2589904 0 2023-03-31 LOW
    Boxer Capital, L.L.C. Hedge Fund 5.5183 2014858 0 2023-03-31 LOW
    Invus Public Equities Advisors, LLC Investment Advisor 4.5095 1646517 0 2023-03-31 LOW
    EcoR1 Capital, LLC Hedge Fund 3.2621 1191094 908963 2023-03-31 LOW
    Epstein (David M) Individual Investor 2.5703 938479 0 2023-03-15 LOW
    Millennium Management LLC Hedge Fund 2.1269 776594 252037 2023-03-31 HIGH
    The Vanguard Group, Inc. Investment Advisor/Hedge Fund 2.0749 757585 0 2023-03-31 LOW
    Citadel Advisors LLC Hedge Fund 1.5276 557771 -216027 2023-03-31 HIGH
    BlackRock Institutional Trust Company, N.A. Investment Advisor 1.4344 523719 -127676 2023-03-31 LOW
    Verition Fund Management LLC Hedge Fund 0.943 344307 344307 2023-03-31 HIGH
    Newtyn Management, LLC Hedge Fund 0.8397 306609 -8391 2023-03-31 MED
    Two Sigma Investments, LP Hedge Fund 0.7769 283654 -72510 2023-03-31 HIGH
    Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.7406 270428 5138 2023-03-31 LOW
    Renaissance Technologies LLC Hedge Fund 0.5957 217500 -3113 2023-03-31 HIGH
    BlackRock Financial Management, Inc. Investment Advisor/Hedge Fund 0.5023 183398 -102283 2023-03-31 LOW
    BioImpact Capital LLC Investment Advisor/Hedge Fund 0.3968 144888 0 2023-03-31 LOW
    Tekla Capital Management LLC Investment Advisor 0.3615 131990 0 2023-03-31 LOW

    为什么选择 Capital.com？让我们的数字来说话。

    Capital.com Group

    535K+

    交易者

    87K+

    每月活跃客户

    $113M+

    每月投资额

    $64M+

    每月提取金额

    交易计算器

    如果您在特定日期（选择一个日期）开立差价合约交易并在不同日期（选择一个日期）关闭交易，计算您的假设盈亏。

    交易佣金
    0
    • 1:1
    杠杆
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    投资
    交易规模（杠杆 x 投资）：
    開倉

    平仓

    做空 做多
    過去的表現並不是未來結果的可靠指標
    盈利/盈利/亏损

    Black Diamond Therapeutics, Inc. Company profile

    关于 Black Diamond Therapeutics Inc

    Black Diamond Therapeutics, Inc.是一家精准肿瘤医学公司。 该公司专注于发现和开发小分子、MasterKey疗法。 它建立了一个小分子激酶抑制剂的管道，针对癌症中的一系列驱动突变。 其技术平台--突变-异质-药理学（MAP）平台旨在使其能够分析群体层面的基因测序数据，以发现促进各种肿瘤类型癌症的致癌突变。 其主要候选产品BDTX-189被设计为一种口服的、不可逆的小分子抑制剂，针对ErbB激酶表皮生长因子受体（EGFR）和HER2的48种非经典和经典驱动突变。 BDTX-1535是一种脑渗透抑制剂，针对一系列的EGFR突变，包括异生和典型突变。 它还有一些早期项目，如B-拉夫原癌基因（BRAF）和成纤维细胞生长因子受体（FGFR）。

    Industry: Bio Therapeutic Drugs

    One Main Street, 14th Floor
    CAMBRIDGE
    MASSACHUSETTS 02142
    US

    收入报表

    • Annual
    • Quarterly

    人们也观看

    XRP/USD

    0.51 Price
    +0.640% 1D Chg, %
    多头隔夜费 -0.0753%
    空头隔夜费 0.0069%
    隔夜费时间 21:00 (UTC)
    价差 0.00404

    US100

    14,559.60 Price
    +0.050% 1D Chg, %
    多头隔夜费 -0.0255%
    空头隔夜费 0.0032%
    隔夜费时间 21:00 (UTC)
    价差 1.8

    Oil - Crude

    72.02 Price
    -0.010% 1D Chg, %
    多头隔夜费 -0.0149%
    空头隔夜费 -0.0070%
    隔夜费时间 21:00 (UTC)
    价差 0.03

    Gold

    1,961.72 Price
    -0.040% 1D Chg, %
    多头隔夜费 -0.0184%
    空头隔夜费 0.0102%
    隔夜费时间 21:00 (UTC)
    价差 0.30

    还在找一位您可以信任的经纪商吗？

    加入成为全球535,000万多名交易者的一份子，选择利用Capital.com进行交易吧。

    1. 创建和验证您的账户 2. 进行存款 3. 找到适合您的交易